← Leaderboards
Stephen Hsu
Camellix, Llc
$1,523,674
Attributed
$2,203,184
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $705.8K · FY2017–22$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,203,184 · 4
By mechanism
R42$1,359,020 · 1
R41$844,164 · 3
Top collaborators
- Douglas Peter Dickinson2 shared
Others in their field
Other Emerging Leaders on “Formulation”
- Matthew Johnson · Duke University$56,071,536
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jay Evans · University Of Montana$27,950,292
- Kristin Aillon · Midwest Research Institute$24,965,877
Research focus
FormulationFutureTechnologyEpigallocatechin GallatePublishingBaseHygieneSmall Business Technology Transfer ResearchVirucidePrototypeUniversitiesLegal PatentPalmitatesHandCommercializationPreventConsultBacteriaAnimalsNovel StrategiesEnvironmentCellsEfficacy TestingFunding
Grant awards (5)
Novel Nasal Formulations Containing EC16 for Minimizing COVID-19-Associated Anosmia$384,971
R41 · FY2022 · DC · contact PI
Feasibility study of novel hand hygiene formulations against bacterial spore infection$266,592
R41 · FY2022 · AI · contact PI
Novel sanitizer/disinfectants against viral infections with long-lasting effect$653,249
R42 · FY2020 · AI · contact PI
Novel sanitizer/disinfectants against viral infections with long-lasting effect$705,771
R42 · FY2019 · AI · contact PI
Novel sanitizer against viral infections with long-lasting effect$192,601
R41 · FY2017 · AI · contact PI